Sign in
4

Changes in Ownership

REGENXBIO Inc. Filed Acc 0001562180-17-003045

Director sold 20,000 shares at $32.45 ($649,000)

  • Director acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

HAYDEN DONALD J JR · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-09-27 Exercise or conversion : show line 1 in the form +20,000 $0.85 $17,000 20,000 D
2017-09-27 Sale : show line 2 in the form −20,000 $32.45 $649,000 0 D
Open-market sales · 20,000 sh · avg $32.45 · $649,000

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-09-27 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −20,000 $0.85 2024-09-23 20,000 254,100 D
Loading xslF345X03/primarydocument.xml…